<?xml version="1.0" encoding="UTF-8"?>
<project>
  <language>en</language>
  <availableLanguages>en</availableLanguages>
  <rcn>269916</rcn>
  <id>101200187</id>
  <acronym>CryoLipNano</acronym>
  <teaser>RNA therapeutics are revolutionizing medicine, offering new treatment possibilities for diseases once considered undruggable. Central to the delivery of nucleic acids, especially mRNA, is the use of Lipid Nanoparticles (LNPs) – the most advanced and the only clinically...</teaser>
  <objective>RNA therapeutics are revolutionizing medicine, offering new treatment possibilities for diseases once considered undruggable. Central to the delivery of nucleic acids, especially mRNA, is the use of Lipid Nanoparticles (LNPs) – the most advanced and the only clinically approved gene delivery platform. LNPs protect mRNA from degradation, facilitate its transfer, and ensure delivery into the cell. Despite their potential, the therapeutic potency of RNA-LNPs remains limited due to suboptimal RNA delivery, with &lt;10% of the administered RNA-LNP system reaching the cytoplasm. To this end, crucial gaps persist in our understanding of LNP structure, integrity and their impact on trafficking and RNA delivery.  CryoLipNano aims to advance our knowledge on LNP ultrastructure and intracellular dynamics, by linking – for the first time – lipid composition, morphology, LNP integrity, mRNA localization and trafficking after endocytosis. By integrating physical chemistry with cutting-edge cryo-electron microscopy (cryoEM), advanced imaging techniques, and proteomic analysis, this study will address critical knowledge gaps, ultimately leading to the rational design of second-generation LNP platforms with enhanced efficiency and potency. Moreover, CryoLipNano will establish the first RNA-LNP research hub at the host institute and, alongside with the ERA Chair's launch of the country's first cryoEM facility, will create a new line of expertise in RNA-LNP characterization by cryoEM. This expertise will be valuable not only in Greece, but also for entities across Europe and globally. CryoLipNano will also focus on disseminating the lab’s presence, educating the scientific community and the public about RNA therapeutics and their structural analysis, and inspiring young scientists. Finally, the high-level science and training the fellow will receive, will significantly advance her expertise and enhance her future employability in the field of nanomedicine and RNA therapeutics.</objective>
  <title>Revealing the RNA-LNP ultrastructure and subcellular trafficking using advanced Cryo-electron microscopy and proteomics</title>
  <totalCost>0</totalCost>
  <ecMaxContribution>197263.68</ecMaxContribution>
  <startDate>2026-01-01</startDate>
  <endDate>2027-12-31</endDate>
  <ecSignatureDate>2025-03-27</ecSignatureDate>
  <duration>24</duration>
  <status>SIGNED</status>
  <keywords>Lipid Nanoparticles, mRNA-LNPs, RNA therapeutics, Cryo-electron microscopy, LNP morphology, LNP trafficking, nanostructure analysis, gene delivery</keywords>
  <identifiers>
    <grantDoi>10.3030/101200187</grantDoi>
  </identifiers>
  <validation>
    <euroSciVoc>false</euroSciVoc>
  </validation>
  <sourceUpdateDate>2025-11-07 07:38:48</sourceUpdateDate>
  <contentCreationDate>2025-04-07 11:37:23</contentCreationDate>
  <contentUpdateDate>2025-11-10 15:52:11</contentUpdateDate>
  <lastUpdateDate>2025-11-10 15:52:14</lastUpdateDate>
  <relations>
    <associations>
      <call source="corda" type="relatedMasterCall">
        <rcn>56116</rcn>
        <title>HORIZON-MSCA-2024-PF-01</title>
        <identifier>HORIZON-MSCA-2024-PF-01</identifier>
      </call>
      <call source="corda" type="relatedSubCall">
        <rcn>56116</rcn>
        <title>HORIZON-MSCA-2024-PF-01</title>
        <identifier>HORIZON-MSCA-2024-PF-01</identifier>
      </call>
      <organization netEcContribution="197263.68" totalCost="0" source="corda" order="1" ecContribution="197263.68" terminated="false" sme="false" type="coordinator">
        <availableLanguages>en</availableLanguages>
        <rcn>1905593</rcn>
        <id>999479853</id>
        <vatNumber>EL090003416</vatNumber>
        <legalName>ETHNIKO IDRYMA EREVNON</legalName>
        <shortName>NATIONAL HELLENIC RESEARCH FOUNDATION EIE NHRF</shortName>
        <address>
          <street>VAS KONSTANTINOU 48</street>
          <city>ATHINA</city>
          <postalCode>116 35</postalCode>
          <country>EL</country>
          <postBox>000</postBox>
          <url>http://www.eie.gr</url>
          <geolocation>37.9841493,23.7279843</geolocation>
        </address>
        <relations>
          <categories>
            <category classification="organizationActivityType" type="relatedOrganizationActivityType">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/REC</code>
              <title>Research Organisations</title>
              <displayCode>/Research Organisations</displayCode>
            </category>
          </categories>
          <regions>
            <region type="relatedNutsCode">
              <name>Κεντρικός Τομέας Αθηνών</name>
              <rcn>1465456</rcn>
              <nutsCode>EL303</nutsCode>
              <parents>
                <region>
                  <name>Aττική</name>
                  <rcn>1464908</rcn>
                  <nutsCode>EL30</nutsCode>
                  <parents>
                    <region>
                      <name>Αττική</name>
                      <rcn>1464907</rcn>
                      <nutsCode>EL3</nutsCode>
                      <parents>
                        <region>
                          <name>Greece</name>
                          <rcn>240552488</rcn>
                          <nutsCode>EL</nutsCode>
                          <euCode>EL</euCode>
                          <isoCode>EL</isoCode>
                        </region>
                      </parents>
                    </region>
                  </parents>
                </region>
              </parents>
            </region>
            <region type="relatedRegion">
              <name>Greece</name>
              <rcn>240552488</rcn>
              <nutsCode>EL</nutsCode>
              <euCode>EL</euCode>
              <isoCode>EL</isoCode>
            </region>
          </regions>
        </relations>
      </organization>
      <programme type="relatedLegalBasis" source="corda" uniqueProgrammePart="true">
        <availableLanguages>en</availableLanguages>
        <rcn>705729</rcn>
        <id>HORIZON.1.2</id>
        <code>HORIZON.1.2</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <pga>HORIZON.1.2</pga>
        <title>Marie Skłodowska-Curie Actions (MSCA)</title>
        <parent>
          <programme>
            <rcn>705726</rcn>
            <code>HORIZON.1</code>
            <parent>
              <programme>
                <rcn>705725</rcn>
                <code>HORIZON</code>
              </programme>
            </parent>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/legalbasis</code>
              <title>Legal Basis</title>
              <description>Programme: Legal basis for research funding</description>
              <displayCode>/Legal Basis</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
      <programme type="relatedTopic" source="corda">
        <availableLanguages>en</availableLanguages>
        <rcn>708088</rcn>
        <id>HORIZON_HORIZON-MSCA-2024-PF-01-01</id>
        <code>HORIZON-MSCA-2024-PF-01-01</code>
        <frameworkProgramme>HORIZON</frameworkProgramme>
        <title>MSCA Postdoctoral Fellowships 2024</title>
        <parent>
          <programme>
            <rcn>20300</rcn>
            <code>HORIZON-Topics</code>
          </programme>
        </parent>
        <relations>
          <categories>
            <category classification="collection" type="belongsTo">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/topic</code>
              <title>Topic</title>
              <description>Programme: Part of the Commission work programme implementing legal basis</description>
              <displayCode>/Topic</displayCode>
            </category>
            <category classification="source" type="isProvidedBy">
              <language>en</language>
              <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
              <code>/corda</code>
              <title>CORDA</title>
              <description>RTD research data warehouse</description>
              <displayCode>/CORDA</displayCode>
            </category>
          </categories>
        </relations>
      </programme>
    </associations>
    <categories>
      <category classification="collection" type="belongsTo">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/project</code>
        <title>Project</title>
        <description>Project factsheets</description>
        <displayCode>/Project</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/315/997/1613/1815</code>
        <title>proteomics</title>
        <displayCode>/natural sciences/biological sciences/biochemistry/biomolecules/proteins/proteomics</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/43/251/48354418</code>
        <title>microscopy</title>
        <displayCode>/natural sciences/physical sciences/optics/microscopy</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/21/37/171</code>
        <title>nanomedicine</title>
        <displayCode>/medical and health sciences/medical biotechnology/nanomedicine</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/23/49/337/1021</code>
        <title>RNA</title>
        <displayCode>/natural sciences/biological sciences/genetics/RNA</displayCode>
      </category>
      <category classification="euroSciVoc" type="isInFieldOfScience">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/25/69/435</code>
        <title>nano-materials</title>
        <displayCode>/engineering and technology/nanotechnology/nano-materials</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/digitalAgenda</code>
        <title>Digital agenda</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development of digital technologies and the digitisation of the economy and society (known as ‘Digital transition’).</description>
        <displayCode>/Digital agenda</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/cleanAir</code>
        <title>Clean air</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to the clean air policy (National Emission Ceiling Directive) aiming to improve ambient air quality and tackle air pollution, to protect the environment and human health.</description>
        <displayCode>/Clean air</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="40">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/ai</code>
        <title>Artificial intelligence</title>
        <description>This tracker monitors Horizon Europe’s financial contribution to the development and deployment of AI-based technologies and solutions. Projects that develop AI-tools as part of their research method are included</description>
        <displayCode>/Artificial intelligence</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/climate</code>
        <title>Climate action</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to both mitigating climate change (e.g., contributions to the reduction of greenhouse gas emissions) and adapting to climate change by building resilience (e.g., regarding floods, droughts, spatial planning and better governance, adaptation to changing climate in value chains, etc.).</description>
        <displayCode>/Climate action</displayCode>
      </category>
      <category classification="policyPriorities" type="marker" weight="0">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/biodiversity</code>
        <title>Biodiversity</title>
        <description>This tracker monitors the Horizon Europe’s financial contribution to Europe’s biodiversity’s path to recovery including species protection, ecosystem conservation, and habitat rehabilitation, all essential for resilience in climate adaptation and addressing ecosystem services but also environmental crime and the health-environment connection.</description>
        <displayCode>/Biodiversity</displayCode>
      </category>
      <category classification="projectFundingSchemeCategory" type="relatedProjectFundingSchemeCategory">
        <language>en</language>
        <availableLanguages>en</availableLanguages>
        <code>/HORIZON-TMA-MSCA-PF-EF</code>
        <title>HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</title>
        <description>HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</description>
        <displayCode>/HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships</displayCode>
      </category>
      <category classification="source" type="isProvidedBy">
        <language>en</language>
        <availableLanguages>de,en,es,fr,it,pl</availableLanguages>
        <code>/corda</code>
        <title>CORDA</title>
        <description>RTD research data warehouse</description>
        <displayCode>/CORDA</displayCode>
      </category>
    </categories>
  </relations>
</project>